X4 Pharmaceuticals (XFOR)
(Delayed Data from NSDQ)
$0.70 USD
+0.01 (1.55%)
Updated Jul 12, 2024 04:00 PM ET
After-Market: $0.70 0.00 (-0.30%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMIndustry / Sector Report
Industry : Medical - Biomedical and Genetics
Zacks Industry Rank
Top 30% (75 out of 250)Zacks Sector Rank
Top 25% (4 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 1.33 | 1.35 | 9.99 |
Current Quarter Estimate | -0.05 | 7.43 | 61.00 |
Year Ago Quarter Estimate | -0.33 | 0.12 | 54.84 |
Next Quarter Estimate | -0.17 | 7.81 | 63.00 |
Next Year Estimate | -0.45 | 37.76 | 270.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | 3.51 | 15.40 | 15.67 |
Next Year | 18.18 | 10.20 | 9.31 |
Last 5 Years | NA | 1.00 | 8.10 |
Next 5 Years | NA | 20.40 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | NA | -2.18 |
Price/Book (MRQ) | NA | 1.88 |
Price/Cash Flow (MRFY) | NA | 15.95 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | NA | -100.57% |
Return on Equity (TTM) | -275.36% | -21.50% |
Debt to Equity (MRQ) | NA | 0.13 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.